Yifan Pharmaceutical: The decrease in net profit in the first quarter was mainly due to the decrease in the revenue from the company's cooperative products entering the centralized procurement-related pharmaceutical services last year.


Full Data

?
UNLOCK DATA

Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login




Related Data